Novasep has expanded its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities on its Le Mans, France site.   To support this growth and sustain the increase in both clinical and commercial production capacity, Novasep is recruiting more than 30 people at this site, combined with an investment of more than €4 million.   Novasep has been a key partner to innovators in the ADC arena for more than 15 years. With a strong pipeline of customer’s clinical drug candidates ...